• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacological comparison of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment.

作者信息

Grady S R, Grun E U, Marks M J, Collins A C

机构信息

Institute for Behavioral Genetics, University of Colorado, Boulder 80309, USA.

出版信息

J Pharmacol Exp Ther. 1997 Jul;282(1):32-43.

PMID:9223537
Abstract

L-Nicotine stimulates a biphasic release of [3H]dopamine from mouse striatal synaptosomes which does not persist after agonist is removed. Approximately 80% of the initial release is transient and disappears with a half-time of less than 1 min; the other 20% persists for several minutes (t(1/2), 5-10 min). Both the transient and persistent phases were investigated by 10-min exposures to agonists with an in vitro perfusion technique. A series of nicotinic agonists and antagonists were used to determine the pharmacological relationship of the two phases. Parameters measured included EC50 and Vmax values and desensitization rates for both phases for agonists, Ki values for antagonists and Ki values for low concentrations of agonists. The results are consistent with both phases being mediated by a single type of receptor. In addition, the effects of chronic nicotine treatment on transient and persistent [3H]DA release were measured. For both phases, release was decreased approximately 15% by chronic infusion of 4.0 mg/kg/hr L-nicotine. Correlation of the results with inactivation of a portion of the receptors rather than a reversible desensitization is discussed.

摘要

相似文献

1
Pharmacological comparison of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment.
J Pharmacol Exp Ther. 1997 Jul;282(1):32-43.
2
Downregulation of nicotinic receptor function after chronic nicotine infusion.长期输注尼古丁后烟碱受体功能的下调。
J Pharmacol Exp Ther. 1993 Sep;266(3):1268-76.
3
(S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.(S)-(-)-可替宁是尼古丁在大脑中的主要代谢产物,它能刺激烟碱受体,以钙依赖的方式引起大鼠纹状体切片释放[3H]多巴胺。
J Pharmacol Exp Ther. 1999 Mar;288(3):905-11.
4
Desensitization of nicotinic agonist-induced [3H]gamma-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists.
J Pharmacol Exp Ther. 1999 Dec;291(3):1127-34.
5
Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.安非他酮对烟碱受体诱发的大鼠纹状体突触体和脑片中[³H]多巴胺释放影响的比较
Eur J Pharmacol. 2007 Jul 12;567(1-2):102-9. doi: 10.1016/j.ejphar.2007.03.052. Epub 2007 Apr 6.
6
Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes.烟碱受体刺激小鼠脑突触体释放γ-氨基丁酸的药理学特性
J Pharmacol Exp Ther. 1998 Nov;287(2):648-57.
7
Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes.
J Neurochem. 1994 Apr;62(4):1390-8. doi: 10.1046/j.1471-4159.1994.62041390.x.
8
Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes.烟碱样激动剂在小鼠丘脑突触体的⁸⁶Rb⁺外流激活和脱敏方面存在差异。
J Pharmacol Exp Ther. 1996 Jun;277(3):1383-96.
9
Nicotinic-receptor mediation of S(-)nornicotine-evoked -3H-overflow from rat striatal slices preloaded with -3H-dopamine.烟碱受体介导S(-)去甲烟碱诱发的、来自预先用-3H-多巴胺加载的大鼠纹状体切片的-3H溢出。
J Pharmacol Exp Ther. 1997 Nov;283(2):778-87.
10
Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.介导小鼠多巴胺释放的两类纹状体突触前烟碱型乙酰胆碱受体的亚基组成和药理学特性。
Mol Pharmacol. 2004 Jun;65(6):1526-35. doi: 10.1124/mol.65.6.1526.

引用本文的文献

1
Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.背侧和腹侧纹状体中的胆碱能中间神经元:正常和疾病状态下的解剖学与功能考量
Ann N Y Acad Sci. 2015 Sep;1349(1):1-45. doi: 10.1111/nyas.12762. Epub 2015 Apr 15.
2
Understanding the role α7 nicotinic receptors play in dopamine efflux in nucleus accumbens.了解α7烟碱型受体在伏隔核多巴胺释放中所起的作用。
ACS Chem Neurosci. 2014 Oct 15;5(10):1032-40. doi: 10.1021/cn500126t. Epub 2014 Aug 29.
3
Presynaptic GABAB autoreceptor regulation of nicotinic acetylcholine receptor mediated [(3)H]-GABA release from mouse synaptosomes.
突触前GABAB自身受体对烟碱型乙酰胆碱受体介导的小鼠突触体[(3)H]-GABA释放的调节
Biochem Pharmacol. 2014 Sep 1;91(1):87-96. doi: 10.1016/j.bcp.2014.06.010. Epub 2014 Jun 19.
4
Targeting nicotinic receptors for Parkinson's disease therapy.针对帕金森病治疗的烟碱型乙酰胆碱受体。
CNS Neurol Disord Drug Targets. 2011 Sep 1;10(6):651-8. doi: 10.2174/187152711797247849.
5
α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief.α4β2 烟碱型乙酰胆碱受体在多巴胺能神经元中介导尼古丁奖赏和焦虑缓解。
J Neurosci. 2011 Jul 27;31(30):10891-902. doi: 10.1523/JNEUROSCI.0937-11.2011.
6
Exploring behavioral and molecular mechanisms of nicotine reward in adolescent mice.探索尼古丁奖赏在青少年小鼠中的行为和分子机制。
Biochem Pharmacol. 2011 Oct 15;82(8):1008-14. doi: 10.1016/j.bcp.2011.06.019. Epub 2011 Jun 25.
7
Reward, addiction, withdrawal to nicotine.奖赏、成瘾、尼古丁戒断。
Annu Rev Neurosci. 2011;34:105-30. doi: 10.1146/annurev-neuro-061010-113734.
8
Cellular events in nicotine addiction.尼古丁成瘾中的细胞事件。
Semin Cell Dev Biol. 2009 Jun;20(4):418-31. doi: 10.1016/j.semcdb.2009.01.001. Epub 2009 Jan 20.
9
Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine.尼古丁利用伏隔核和背侧纹状体中的多巴胺信号差异。
J Neurosci. 2009 Apr 1;29(13):4035-43. doi: 10.1523/JNEUROSCI.0261-09.2009.
10
The road to discovery of neuronal nicotinic cholinergic receptor subtypes.神经元烟碱型胆碱能受体亚型的发现之路。
Handb Exp Pharmacol. 2009(192):85-112. doi: 10.1007/978-3-540-69248-5_4.